Copyright Reports & Markets. All rights reserved.

Global LV-Based Cell and Gene Therapy Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of LV-Based Cell and Gene Therapy Products by Type
    • 1.3.1 Overview: Global LV-Based Cell and Gene Therapy Products Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type in 2023
    • 1.3.3 CAR-T Therapy
    • 1.3.4 Autologous CD34+ Cell Gene Therapy
  • 1.4 Global LV-Based Cell and Gene Therapy Products Market by Application
    • 1.4.1 Overview: Global LV-Based Cell and Gene Therapy Products Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic and Testing Laboratories
    • 1.4.4 Academic and Research Organizations
    • 1.4.5 Others
  • 1.5 Global LV-Based Cell and Gene Therapy Products Market Size & Forecast
  • 1.6 Global LV-Based Cell and Gene Therapy Products Market Size and Forecast by Region
    • 1.6.1 Global LV-Based Cell and Gene Therapy Products Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global LV-Based Cell and Gene Therapy Products Market Size by Region, (2019-2030)
    • 1.6.3 North America LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
    • 1.6.4 Europe LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
    • 1.6.6 South America LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.1.4 Novartis LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novartis Recent Developments and Future Plans
  • 2.2 Bluebird Bio
    • 2.2.1 Bluebird Bio Details
    • 2.2.2 Bluebird Bio Major Business
    • 2.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.2.4 Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bluebird Bio Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.3.4 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 Intas
    • 2.4.1 Intas Details
    • 2.4.2 Intas Major Business
    • 2.4.3 Intas LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.4.4 Intas LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Intas Recent Developments and Future Plans
  • 2.5 BMS
    • 2.5.1 BMS Details
    • 2.5.2 BMS Major Business
    • 2.5.3 BMS LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.5.4 BMS LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BMS Recent Developments and Future Plans
  • 2.6 Orchard Therapeutics
    • 2.6.1 Orchard Therapeutics Details
    • 2.6.2 Orchard Therapeutics Major Business
    • 2.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product and Solutions
    • 2.6.4 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Orchard Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global LV-Based Cell and Gene Therapy Products Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of LV-Based Cell and Gene Therapy Products by Company Revenue
    • 3.2.2 Top 3 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
    • 3.2.3 Top 6 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
  • 3.3 LV-Based Cell and Gene Therapy Products Market: Overall Company Footprint Analysis
    • 3.3.1 LV-Based Cell and Gene Therapy Products Market: Region Footprint
    • 3.3.2 LV-Based Cell and Gene Therapy Products Market: Company Product Type Footprint
    • 3.3.3 LV-Based Cell and Gene Therapy Products Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global LV-Based Cell and Gene Therapy Products Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global LV-Based Cell and Gene Therapy Products Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global LV-Based Cell and Gene Therapy Products Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
  • 6.2 North America LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2030)
  • 6.3 North America LV-Based Cell and Gene Therapy Products Market Size by Country
    • 6.3.1 North America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
    • 6.3.2 United States LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 6.3.3 Canada LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
  • 7.2 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
  • 7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Country
    • 7.3.1 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
    • 7.3.2 Germany LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 7.3.3 France LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 7.3.5 Russia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 7.3.6 Italy LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region
    • 8.3.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Region (2019-2030)
    • 8.3.2 China LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 8.3.3 Japan LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 8.3.5 India LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 8.3.7 Australia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
  • 9.2 South America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
  • 9.3 South America LV-Based Cell and Gene Therapy Products Market Size by Country
    • 9.3.1 South America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country
    • 10.3.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
    • 10.3.4 UAE LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 LV-Based Cell and Gene Therapy Products Market Drivers
  • 11.2 LV-Based Cell and Gene Therapy Products Market Restraints
  • 11.3 LV-Based Cell and Gene Therapy Products Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 LV-Based Cell and Gene Therapy Products Industry Chain
  • 12.2 LV-Based Cell and Gene Therapy Products Upstream Analysis
  • 12.3 LV-Based Cell and Gene Therapy Products Midstream Analysis
  • 12.4 LV-Based Cell and Gene Therapy Products Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.
    According to our (Global Info Research) latest study, the global LV-Based Cell and Gene Therapy Products market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global LV-Based Cell and Gene Therapy Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global LV-Based Cell and Gene Therapy Products market size and forecasts, in consumption value ($ Million), 2019-2030
    Global LV-Based Cell and Gene Therapy Products market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global LV-Based Cell and Gene Therapy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global LV-Based Cell and Gene Therapy Products market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for LV-Based Cell and Gene Therapy Products
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global LV-Based Cell and Gene Therapy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    LV-Based Cell and Gene Therapy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    LV-Based Cell and Gene Therapy Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    CAR-T Therapy
    Autologous CD34+ Cell Gene Therapy
    Market segment by Application
    Hospital
    Diagnostic and Testing Laboratories
    Academic and Research Organizations
    Others
    Market segment by players, this report covers
    Novartis
    Bluebird Bio
    Thermo Fisher Scientific
    Intas
    BMS
    Orchard Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe LV-Based Cell and Gene Therapy Products product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of LV-Based Cell and Gene Therapy Products, with revenue, gross margin, and global market share of LV-Based Cell and Gene Therapy Products from 2019 to 2024.
    Chapter 3, the LV-Based Cell and Gene Therapy Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and LV-Based Cell and Gene Therapy Products market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of LV-Based Cell and Gene Therapy Products.
    Chapter 13, to describe LV-Based Cell and Gene Therapy Products research findings and conclusion.

    Buy now